Results 161 to 170 of about 323,582 (308)
openaire +1 more source
A sustainable business ecosystem: a case study demonstrating biochar's potential
Abstract The need for renewable, climate‐friendly resources has become urgent as legislators worldwide have sought to find ways to cut emissions while ensuring resource security for consumers. The use of biochar could help to achieve these goals. This study examines the current state of commercial biochar production and the maturity of the related ...
Kivijakola Juuso +4 more
wiley +1 more source
Public regulatory policy: interaction of business and power [PDF]
Khomenko, Ludmyla et al, Seheda, Serhiy
core
Aims In medical education, the ability of large language models (LLMs) to match human performance raises questions about their potential as educational tools. This study evaluates LLMs' performance on Clinical Pharmacology and Therapeutics (CPT) exams, comparing their results to medical students and exploring their ability to identify poorly formulated
Alexandre O. Gérard +11 more
wiley +1 more source
Statutory regulation in somatology: a public health, professional, and decolonial imperative in South Africa. [PDF]
Mpofana N +6 more
europepmc +1 more source
THE CONCEPT OF THE MECHANISM OF ADMINISTRATIVE AND LEGAL REGULATION OF LABOUR PROTECTION IN UKRAINE
openaire +1 more source
Within the ConcePTION project we set out to design two mother–infant pair studies collecting breast milk and plasma from the mother and plasma from the infant (for metformin and prednisolone) in order to demonstrate the premises and conditions for investigating potential drug transfer in association with breastfeeding.
Mats Hansson +11 more
wiley +1 more source
Animal models of critical illness in the Asia-Pacific region: current practices, shared challenges, and future directions. [PDF]
Fujinami Y +6 more
europepmc +1 more source
Effects of Renal and Hepatic Impairment on the Pharmacokinetics of Zilurgisertib
Aim Small‐molecule activin receptor‐like kinase‐2 inhibitor zilurgisertib (INCB000928) is under investigation in a pivotal trial for the treatment of fibrodysplasia ossificans progressiva (FOP), an ultrarare genetic condition. This analysis assessed effects of renal and hepatic impairment on zilurgisertib pharmacokinetics.
Yan‐ou Yang +5 more
wiley +1 more source

